Maja Cemazar

46PUBLICATIONS
99CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsMolecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 25, 2026
Multiparametric Flow Cytometry Panel for Characterization of Mouse T Cell Differentiation and NK Cell Maturation Following Inflammatory Challenge.

|May 20, 2026
Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium Cations.

|Mar 28, 2026
Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Federica Tonon, Maja Cemazar, Urska Kamensek

|Jan 10, 2026
Effect of Bleomycin Hydrolase Expression in Tumor Tissue on the Therapeutic Effectiveness of Electrochemotherapy.

Jan Bogataj, Ursa Lampreht Tratar, Gregor Sersa

|Jan 10, 2026
Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles.

Masa Omerzel, Simona Kranjc Brezar, Ursa Lampreht Tratar

|Aug 14, 2025
In Vitro Evaluation of Electrochemotherapy Combined with Sotorasib in Pancreatic Carcinoma Cell Lines Harboring Distinct KRAS Mutations.

Tanja Jesenko, Masa Omerzel, Tina Zivic

Pageof 8

Frequent Collaborators

27 joint publications

Gregor Sersa

15 joint publications

Urska Kamensek

13 joint publications

Masa Omerzel

8 joint publications

Tanja Jesenko